Chronos Therapeutics Company

Targetting neurological, neurodegenerative disease such as ALS and MS. Chronos is an Oxford-based biotechnology company operating a semi-virtual R&D model to develop a portfolio of therapies in degenerative and behavioral brain diseases. The team utilises a network of industry-leading contract research organisations to develop NCE’s and repurpose existing launched drugs. Chronos also has a dedicated laboratory in Oxford which screens for activity of drugs in brain disease through its proprietary platform, Chronoscreen.
Technology: AgeTech Companies
Industry: Healthcare
Headquarters: United Kingdom
Founded Date: 2009
Employees Number: 11-50
Funding Status: M&A
Investors Number: 3
Total Funding: £8M
Estimated Revenue: $1M to $10M
Last Funding Type: Venture - Series Unknown

Visit Website
info@chronostherapeutics.com
Register and Claim Ownership